Chest complaints more costly in obese patients

March 8, 2014
Chest complaints more costly in obese patients

(HealthDay)—Higher body mass index (BMI) is associated with increased cost of care and longer hospital stays for patients who present to the emergency department with chest pain and dyspnea, according to research published online March 4 in Circulation: Cardiovascular Quality and Outcomes.

Geoffrey W. Peitz, of the Indiana University School of Medicine in Indianapolis, and colleagues prospectively analyzed costs and outcomes stratified by BMI for patients presenting to the with and dyspnea.

The researchers found that costs of care were 41 percent higher for morbidly (P = 0.015), 28 percent higher for obese patients (P = 0.020), and 22 percent higher for (P = 0.077), than for normal-weight patients. Compared with normal-weight patients, morbidly obese patients had longer lengths of hospital stay with or without computed tomography (CT) scanning (44 percent longer with CT [P = 0.083]; 34 percent longer without CT [P = 0.073]). Morbidly obese patients had the highest rate (87 percent) of no significant cardiopulmonary diagnosis for 90 days after CT pulmonary angiography.

"These findings substantiate the need for clinical protocols that reduce overuse of imaging in patients with high BMI and chest complaints," the authors write.

Explore further: Morbid obesity ups complication rate in spinal fusion surgery

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Chest pain duration can signal heart attack

September 11, 2013

Patients with longer-lasting chest pain are more likely having a heart attack than those with pain of a shorter duration, according to a study by researchers at Henry Ford Hospital.

Recommended for you

No new heart muscle cells in mice after the newborn period

November 5, 2015

A new study from Sweden's Karolinska Institutet shows that new heart muscle cells in mice are mainly formed directly after birth. After the neonatal period the number of heart muscle cells does not change, and A new study ...

Nanotechnology could spur new heart treatment

October 29, 2015

A new nanoparticle developed by University of Michigan researchers could be the key to a targeted therapy for cardiac arrhythmia, a condition that causes the heart to beat erratically and can lead to heart attack and stroke.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.